Cargando…
PIK3CA amplification and PTEN loss in diffused large B-cell lymphoma
Although it has been known that PIK3CA was amplified and PTEN was deficient on protein level in DLBCL, the clinicopathological significance of PIK3CA and PTEN genetic change on DNA level hasn’t been established. Here, in our present study, to understand the clinical significance of genetic status of...
Autores principales: | Cui, Wenli, Ma, Mingfu, Zheng, Shutao, Ma, Zhiping, Su, Liping, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630407/ https://www.ncbi.nlm.nih.gov/pubmed/29029507 http://dx.doi.org/10.18632/oncotarget.19889 |
Ejemplares similares
-
PIK3CA expression in diffuse large B cell lymphoma tissue and the effect of its knockdown in vitro
por: Cui, Wenli, et al.
Publicado: (2017) -
PIK3CA and PTEN Genes Expressions in Breast Cancer
por: Alowiri, Nabil Hadi, et al.
Publicado: (2019) -
Prospective phase II trial of everolimus in PIK3CA amplification/mutation and/or PTEN loss patients with advanced solid tumors refractory to standard therapy
por: Kim, Seung Tae, et al.
Publicado: (2017) -
KRAS, BRAF and PIK3CA Mutations and the Loss of PTEN Expression in Chinese Patients with Colorectal Cancer
por: Mao, Chen, et al.
Publicado: (2012) -
Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma
por: Wang, Xiaoxiao, et al.
Publicado: (2018)